
Sign up to save your podcasts
Or


This week two research groups announced that they have made synthetic mouse embryos that developed brains and beating hearts in the test tube, starting only with embryonic stem cells. No sperm and eggs were involved. Previously, embryos created this way have never got beyond the stage of being a tiny ball of cells. These embryos grew and developed organs through 8 days – more than a third of the way through the gestation period for a mouse. Roland Pease talks to the leader of one of the teams, developmental biologist Magdalena Zernicka-Goetz of Cambridge University and Caltech about how and why they did this, and the ethical issues around this research.
Also in the programme: the latest research on how we spread the SARS-CoV-2 virus when we breathe. Infectious disease researcher Kristen Coleman of the University of Maryland tells us about her experiments that have measured the amounts of virus in the tiny aerosol particles emanating from the airways of recently infected people. The results underscore the value of mask-wearing and effective ventilation in buildings.
We also hear about new approaches to vaccines against the virus – Kevin Ng of the Crick Institute in London talks about the possibility of a universal coronavirus vaccine based on his research, and immunologist Akiko Iwasaki of Yale University extolls the advantages of nasal vaccines against SARS-CoV-2.
(Image: Stem cell built mouse embryo at 8 days. Credit: Zernicka-Goetz Lab)
Presenter: Roland Pease
By BBC World Service4.5
327327 ratings
This week two research groups announced that they have made synthetic mouse embryos that developed brains and beating hearts in the test tube, starting only with embryonic stem cells. No sperm and eggs were involved. Previously, embryos created this way have never got beyond the stage of being a tiny ball of cells. These embryos grew and developed organs through 8 days – more than a third of the way through the gestation period for a mouse. Roland Pease talks to the leader of one of the teams, developmental biologist Magdalena Zernicka-Goetz of Cambridge University and Caltech about how and why they did this, and the ethical issues around this research.
Also in the programme: the latest research on how we spread the SARS-CoV-2 virus when we breathe. Infectious disease researcher Kristen Coleman of the University of Maryland tells us about her experiments that have measured the amounts of virus in the tiny aerosol particles emanating from the airways of recently infected people. The results underscore the value of mask-wearing and effective ventilation in buildings.
We also hear about new approaches to vaccines against the virus – Kevin Ng of the Crick Institute in London talks about the possibility of a universal coronavirus vaccine based on his research, and immunologist Akiko Iwasaki of Yale University extolls the advantages of nasal vaccines against SARS-CoV-2.
(Image: Stem cell built mouse embryo at 8 days. Credit: Zernicka-Goetz Lab)
Presenter: Roland Pease

7,596 Listeners

890 Listeners

1,049 Listeners

5,454 Listeners

1,798 Listeners

1,752 Listeners

1,042 Listeners

2,093 Listeners

600 Listeners

764 Listeners

79 Listeners

90 Listeners

973 Listeners

410 Listeners

418 Listeners

824 Listeners

821 Listeners

235 Listeners

352 Listeners

477 Listeners

3,186 Listeners

711 Listeners

110 Listeners

1,615 Listeners